Pharmacology Research & Perspectives
© John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics
Articles are published under the terms of the Creative Commons License as stated in the final article.
Recently Published Issues
Articles, selected by the Editors, that warrant special attention. Read them today
Call for Papers
Meet the Editors
See the New Editors discuss PR&P and its future – short 6 minute video.
Editor in Chief: Darrell Abernethy
Darrell is Professor of Medicine and Pharmacology and Molecular Science (part-time), Johns Hopkins Univ. School of Medicine. He received his M.D. (AOA) and Ph.D. (Pharmacology) degrees from the University of Kansas School of Medicine. Dr. Abernethy is an experienced editor. He served as Editor-in-Chief of Pharmacological Reviews and as an Associate Editor of the Journal of Pharmacology and Experimental Therapeutics among other positions. He has contributed to the understanding of mechanisms of peripheral distribution of drugs and drug disposition and effect in obesity.
Deputy Editor: Andrew Lawrence
As well as being a BPS Fellow, Professor Andrew Lawrence is head of the Behavioural Neuroscience Division at the Florey, overseeing 50 researchers. His primary research interest is in the development of robust animal models of drug-seeking, drug-taking and drug-induced neural adaptation. He has published over 150 original articles and has sat on a number of editorial boards, including his current role as Reviews Editor of The British Journal of Pharmacology. He is also the President of the Asian-Pacific Society for Neurochemistry.
Open for submissions
Pharmacology Research & Perspectives has now been accepted for indexing in PubMed Central (PMC).
Pharmacology Research & Perspectives invites authors to submit research articles and invites submission of several types of special articles. These are:
1. Target validation – publication of negative findings including preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development
2. Drug discovery reviews – strategy, hypotheses and data resulting in a successful therapeutic drug
3. Frontiers in translational medicine – drug and target validation for an unmet therapeutic need
4. Pharmacological hypotheses – reviews that are oriented to inform a novel hypothesis
5. Replication studies - work that refutes key findings (failed replication), and work that validates key findings
Read more about PR&P's support for the publication of negative findings.
PR&P authors benefit from:
• Rapid peer review
• Full compliance with all open access mandates
• Authors retain copyright and articles are published under a Creative Commons License
• Discounts for ASPET and BPS society members and authors at institutions with Wiley accounts
Supported by ASPET and BPS Journals
The following journals published by ASPET and BPS participate in a Manuscript Transfer Program by referring selected articles of suitable quality and offering authors the option to have their paper, with any peer review reports, automatically transferred to Pharmacology Research & Perspectives. Manuscripts are now also transferred from Basic & Clinical Pharmacology & Toxicology (BCPT) and Pharmacoepidemiology and Drug Safety (PDS) if deemed appropriate. We do, of course, encourage direct submission of articles.
|The Journal of Pharmacology and Experimental Therapeutics||British Journal of Pharmacology|
|Molecular Pharmacology||British Journal of Clinical Pharmacology|
|Drug Metabolism and Disposition|